NDC 63323-696
Epinephrine 1 mg per 1 mL injection, solution, concentrate
On the label: Fresenius Kabi, LLC.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Fresenius Kabi USA, LLC | Melrose Park, IL, United States | Makes it and tests it | Problems found, fixed voluntarilyAug 24, 2023 · 13 inspections, 2 with FDA action |
Recalls
- May 14, 2026 · Class III · Fresenius Kabi USA, LLC
Failed Impurities/Degradations Specifications
Lots: Batch # 6133313, 6133314, Exp Date: 06/2026; Batch # 6133315, Exp Date: 07/2026; Batch # 6133682, Exp Date: 09/2026; Batch # 6134812, 6134813, Exp Date: 04/2027.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Epinephrine: every company that makes it
- Form
- injection, solution, concentrate, intramuscular; intraocular; intravenous; subcutaneous
- Strength
- 1 mg per 1 mL
- Approval
- ANDA ANDA213708
- On the market since
- Nov 21, 2024
- Package NDCs
63323-696-0263323-696-25- Official label
- DailyMed (National Library of Medicine), updated Jul 29, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?